Prof. Beisel’s Group
The primary goal of the Beisel lab is to employ reverse-engineered versions of RNA regulators to address current challenges in health and sustainability.
Prof. Hall’s Group
Uses molecular dynamics computer simulation to search for insights in guiding medical research workers directly involved with therapeutic strategies to combat diseases.
Prof. Kelly’s Group
Focuses on using functional genomics approaches (using cDNA microarrays) to characterize the metabolism of hyperthermophiles as well as to identify novel biocatalysts of scientific and technological importance.
Prof. Reeves’ Group
Focuses on signaling networks as at the tissue level in developing animals.
Prof. Wei's Group
The Wei group is developing next-generation field-deployable molecular imaging, sensing, and diagnostic tools for plants and human.
Prof. Flickinger’s Group
Focuses on engineering nanostructured bioreactive materials, bioprocess intensification and miniaturization (BIM) and microchannel bioreactors.
Prof. Carbonell’s Group
Investigates the use of combinatorial peptide libraries to screen for ligands for protein purification.
Prof. Peretti’s Group
Projects involve studies of mixed-culture, mixed-substrate population dynamics and design of reactors for non-aqueous phase bioprocessing.
Prof. DeSimone’s Group
Researches the human body’s biological barriers which pose challenges to achieving effective nanoparticle drug delivery vehicles.
Prof. San Miguel's Group
The San Miguel group is using engineering and systems approaches to understand fundamental biological processes in living organisms, particularly the model organism Caenorhabditis elegans.
Prof. Grant’s Group
Explores the importance of cellular age and cell line selection on the response of human bone cells at their interface with engineered biomaterials.
Prof. Haugh’s Group
Investigates chemical reaction networks that are used for integrating information and prompting decision making by mammalian (e.g. human) cells.
Prof. Rao’s Group
The Rao group is exploring the use of these proteins as novel reagents to perturb biochemical pathways in human embryonic stem cells (hESCs), in the extracellular as well as intracellular context.
Prof. Menegatti's Group
The Menegatti Group is studying stimuli-responsive peptide ligands for purification of stem cells and labile therapeutic proteins.
Prof. Keung's Group
The Keung lab develops molecular technologies to expand and unlock new ways to control, understand, and harness chromatin.